COVID-19
From Pandemic to Endemic? Plus, What’s Up with the Delta Variant?
While the world watches, the viral agent that causes COVID-19 is morphing from the driver of a pandemic…
Read MorePODCAST: The Bio Report: Bringing the Trial to the Patient
One of the challenges to securing the participation of patients in clinical trials can be simple geography. Sanguine…
Read MoreRecovered Coronavirus Patient Donates Blood To Help Vaccine, Treatment Research
WBZ | CBS Boston – Lara Woolfson’s COVID-19 story and her participation with Sanguine for her in-home blood…
Read MoreFrom Serum to Survey – Following an active COVID-19 Patient member community over time
Sanguine Bioscience, a California-based biotechnology company focused on patient recruitment, sample collection engagement and digital health, has partnered…
Read MoreResearching COVID-19
We at Sanguine Bioscience have partnered with multiple biotech and pharmaceutical companies, such as Vir Biotechnology and EpiVax,…
Read MoreSanguine Bio Accelerates Pace in Vaccine Race
Written by Amy Stulick, Staff Reporter, San Fernando Valley Busines Journal Biotech: Blood samples are raw materials for…
Read MoreHow This Medical Research Service Company Is Making House Calls Safe in a Pandemic
Written by Leigh Buchanan, Editor-at-Large for Inc. Magazine. After recovering from Covid-19 in April, Tom Hanks was so chuffed by…
Read MoreCOVID and the Microbiome
Research on the human microbiome has burgeoned in recent years. Microbiome imbalances have been linked to chronic conditions,…
Read MoreOvercoming Study-Patient Burdens in Medical Research During the Pandemic
Written by Brian Neman, Co-Founder & CEO, Sanguine for Pharmaceutical Outsouring Study-patient recruitment and retention continue to be…
Read MoreRecovered Patients Help Sanguine BioSciences Advance COVID-19 Medical Research
Written by Brian Neman, Co-Founder & CEO, Sanguine for Biocom LifeLines Magazine The desire to help during times…
Read More